1Okada S, Shikata K, et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes[J]. Diabetes, 2003 Oct,52(10) :2586. 被引量：1
2Forbes JM, Cooper ME, et al. Role of advanced glycation end products in diabetic nephropathy[J]. J Am Soc Nephrol, 2003,14(8 Suppl 3):S254. 被引量：1
3Omoto S, Nomura S, et al. Significance of platelet-derived microparticles and activated plate lets in diabetic nephropathy[J]. Nephron, 1999,81(3):271. 被引量：1
4Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase:potential relevance in diabetic nephropathy[J]. J Am Soc Nephrol, 2003 Aug, 14(8 Suppl 3):S221. 被引量：1
5Ha H, Lee HB. Reactive oxygen species and matrix remodeling in diabetic kidney[J]. J Am Soc Nephrol, 2003 Aug, 14(8 Suppl 3) :S246. 被引量：1
6Anjaneyulu M, Chopra K. Effect of Irbesartan on the Antioxidant Defence System and Nitric Oxide Release in Diabetic Rat Kidney[J]. Am J Nephrol, 2004 Sep 7,24(5) :488. 被引量：1
7Onozato ML, Tojo A, et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy:effects of ACEI and ARB[J]. Kidney Int, 2002 Jan,61(1) :186. 被引量：1
8Baricos WH, Cortez SL, el-Dahr SS, et al. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade[J].Kidney Int, 1995,47(4): 1039. 被引量：1
9McLennan SV, Yue DK, Tutle JR. Effect of gulose on matrix metalloproteinase activity in mesangial cells[J]. Nephron, 1998,79:293. 被引量：1
10Chen S, Jim B, et al. Diabetic nephropathy and transforming growth factorbeta: transforming our view of glomerulosclerosis and fibrosis build-up.Ziyadeh FN[J]. Semin Nephrol, 2003 Nov,23(6):532. 被引量：1
